ScholarIQanswers from OpenAlex

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

PaperCitations, authors & open-access status

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer have?

ScholarIQcitation count

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer has 646 citations in the OpenAlex counts ScholarIQ stores.

When was Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer published?

ScholarIQyear

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer has 2015 year in the ScholarIQ index.

What is the open-access status of Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer?

ScholarIQoa status

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer has bronze oa status in the ScholarIQ index.

What is the DOI of Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer?

ScholarIQdoi

The DOI for Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer is on the source record.

What is the PMID of Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer?

ScholarIQpmid

The PMID for Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer is on the source record.

What is the OpenAlex record for Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer?

ScholarIQopenalex

The OpenAlex for Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial